Recoverin autoantibodies were detected in serum in <0.1% in neuropsychiatric and neurological disorders, such as schizophrenia, affective disorders, brain ischemia, Parkinson’s disease, amyotrophic lateral sclerosis, or personality disorder in >2500 patients [18]. This evidence concerns the gene RCVRN and nervous system disorder.